Canlyniadau Chwilio - Min‐Ji Charng
- Dangos 1 - 6 canlyniadau o 6
-
1
Efficacy and Safety of Alirocumab in Children and Adolescents With Homozygous Familial Hypercholesterolemia: Phase 3, Multinational Open-Label Study gan Éric Bruckert, Sonia Caprio, Albert Wiegman, Min‐Ji Charng, Cézar A. Zárate-Morales, Marie T. Baccara‐Dinet, Garen Manvelian, Anne Ourliac, Michel Scemama, Stephen R. Daniels
Cyhoeddwyd 2022Artigo -
2
Efficacy and Safety of Alirocumab in Adults With Homozygous Familial Hypercholesterolemia gan Dirk Blom, Mariko Harada–Shiba, Paolo Rubba, Daniel Gaudet, John J.P. Kastelein, Min‐Ji Charng, Robert Pordy, Stephen Donahue, Shazia Ali, Yuping Dong, Nagwa Khilla, Poulabi Banerjee, Marie T. Baccara‐Dinet, Robert S. Rosenson
Cyhoeddwyd 2020Artigo -
3
Evinacumab for Pediatric Patients With Homozygous Familial Hypercholesterolemia gan Albert Wiegman, Susanne Greber‐Platzer, Shazia Ali, M. Doortje Reijman, Eliot A. Brinton, Min‐Ji Charng, Shubha Srinivasan, Carissa M. Baker‐Smith, Seth J. Baum, Julie A. Brothers, Jacob Hartz, Patrick M. Moriarty, Jeanne Mendell, Sébastien Bihorel, Poulabi Banerjee, Richard T. De George, Boaz Hirshberg, Robert Pordy
Cyhoeddwyd 2023Artigo -
4
Comparative aspects of the care of familial hypercholesterolemia in the “Ten Countries Study” gan Jing Pang, Dick C. Chan, Miao Hu, Lauretta Muir, See Kwok, Min-Ji Charng, Christopher M Florkowski, Peter M. George, Jie Lin, Đỗ Doãn Lợi, Adéle Marais, Hapizah Nawawi, Lourdes Gonzalez-Santos, Ta‐Chen Su, Thanh Huong Truong, Raúl D. Santos, Handrean Soran, Brian Tomlinson, Shizuya Yamashita, Zanfina Ademi, Gerald F. Watts
Cyhoeddwyd 2019Artigo -
5
2017 Taiwan lipid guidelines for high risk patients gan Yi‐Heng Li, Kwo‐Chang Ueng, Jiann‐Shing Jeng, Min‐Ji Charng, Tsung‐Hsien Lin, Kuo‐Liong Chien, Chih‐Yuan Wang, Ting‐Hsing Chao, Ping‐Yen Liu, Cheng‐Huang Su, Shih‐Chieh Chien, Chia‐Wei Liou, Sung‐Chun Tang, Chun‐Chuan Lee, Tse‐Ya Yu, Jaw‐Wen Chen, Chau‐Chung Wu, Hung‐I Yeh
Cyhoeddwyd 2017Revisão -
6
Association between Preoperative Nutritional Status and Clinical Outcomes of Patients with Coronary Artery Disease Undergoing Percutaneous Coronary Intervention gan Su-Chan Chen, Ya‐Ling Yang, Cheng-Hsueh Wu, Shao‐Sung Huang, Wan Leong Chan, Shing‐Jong Lin, Chia-Yu Chou, Jaw‐Wen Chen, Ju‐Pin Pan, Min-Ji Charng, Ying-Hwa Chen, Tao-Cheng Wu, Tse-Min Lu, Pai‐Feng Hsu, Po‐Hsun Huang, Hao‐Min Cheng, Chin‐Chou Huang, Shih‐Hsien Sung, Yenn‐Jiang Lin, Hsin‐Bang Leu
Cyhoeddwyd 2020Artigo
Offerynnau Chwilio:
Pynciau Perthynol
Internal medicine
Medicine
Cholesterol
Familial hypercholesterolemia
Endocrinology
Gastroenterology
Adverse effect
Alirocumab
Apolipoprotein A1
Coronary artery disease
LDL receptor
Lipoprotein
Pediatrics
Abdominal pain
Apolipoprotein B
Cardiology
Clinical endpoint
Clinical trial
Conventional PCI
Diabetes mellitus
Economic growth
Economics
Ezetimibe
Family medicine
Guideline
Health care
Heart failure
Kexin
Ldl cholesterol
Lipid profile